Literature DB >> 27728804

Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression.

Tobias Eggert1, Katharina Wolter2, Juling Ji3, Chi Ma1, Tetyana Yevsa2, Sabrina Klotz2, José Medina-Echeverz1, Thomas Longerich4, Marshonna Forgues3, Florian Reisinger5, Mathias Heikenwalder5, Xin Wei Wang3, Lars Zender6, Tim F Greten7.   

Abstract

Oncogene-induced senescence causes hepatocytes to secrete cytokines, which induce their immune-mediated clearance to prevent tumor initiation, a process termed "senescence surveillance." However, senescent hepatocytes give rise to hepatocellular carcinomas (HCCs), if the senescence program is bypassed or if senescent cells are not cleared. Here, we show context-specific roles for CCR2+ myeloid cells in liver cancer. Senescence surveillance requires the recruitment and maturation of CCR2+ myeloid cells, and CCR2 ablation caused outgrowth of HCC. In contrast, HCC cells block the maturation of recruited myeloid precursors, which, through NK cell inhibition, promote growth of murine HCC and worsen the prognosis and survival of human HCC patients. Thus, while senescent hepatocyte-secreted chemokines suppress liver cancer initiation, they may accelerate the growth of fully established HCC. Published by Elsevier Inc.

Entities:  

Keywords:  CCL2; CCR2; HCC; MDSC; NK cells; hepatocellular carcinoma; liver cancer; macrophages; myeloid cells; senescence

Mesh:

Year:  2016        PMID: 27728804      PMCID: PMC7789819          DOI: 10.1016/j.ccell.2016.09.003

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  40 in total

1.  Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity.

Authors:  Alberto Toso; Ajinkya Revandkar; Diletta Di Mitri; Ilaria Guccini; Michele Proietti; Manuela Sarti; Sandra Pinton; Jiangwen Zhang; Madhuri Kalathur; Gianluca Civenni; David Jarrossay; Erica Montani; Camilla Marini; Ramon Garcia-Escudero; Eugenio Scanziani; Fabio Grassi; Pier Paolo Pandolfi; Carlo V Catapano; Andrea Alimonti
Journal:  Cell Rep       Date:  2014-09-25       Impact factor: 9.423

2.  Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.

Authors:  Carlo Schneider; Andreas Teufel; Tetyana Yevsa; Frank Staib; Anja Hohmeyer; Gudrun Walenda; Henning W Zimmermann; Mihael Vucur; Sebastian Huss; Nikolaus Gassler; Hermann E Wasmuth; Sergio A Lira; Lars Zender; Tom Luedde; Christian Trautwein; Frank Tacke
Journal:  Gut       Date:  2012-01-20       Impact factor: 23.059

3.  Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging.

Authors:  A Krtolica; S Parrinello; S Lockett; P Y Desprez; J Campisi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

4.  Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions.

Authors:  Yan Wu; Dong-Ming Kuang; Wei-Dong Pan; Yun-Le Wan; Xiang-Ming Lao; Dian Wang; Xue-Feng Li; Limin Zheng
Journal:  Hepatology       Date:  2013-01-18       Impact factor: 17.425

5.  Infiltrating monocyte-derived macrophages and resident kupffer cells display different ontogeny and functions in acute liver injury.

Authors:  Ehud Zigmond; Shany Samia-Grinberg; Metsada Pasmanik-Chor; Eli Brazowski; Oren Shibolet; Zamir Halpern; Chen Varol
Journal:  J Immunol       Date:  2014-06-02       Impact factor: 5.422

6.  Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network.

Authors:  Thomas Kuilman; Chrysiis Michaloglou; Liesbeth C W Vredeveld; Sirith Douma; Remco van Doorn; Christophe J Desmet; Lucien A Aarden; Wolter J Mooi; Daniel S Peeper
Journal:  Cell       Date:  2008-06-13       Impact factor: 41.582

Review 7.  Myeloid-derived suppressor cells as regulators of the immune system.

Authors:  Dmitry I Gabrilovich; Srinivas Nagaraj
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

8.  A role for CCL2 in both tumor progression and immunosurveillance.

Authors:  Ming Li; Deborah A Knight; Linda A Snyder; Mark J Smyth; Trina J Stewart
Journal:  Oncoimmunology       Date:  2013-07-01       Impact factor: 8.110

9.  Early CD8 T-cell memory precursors and terminal effectors exhibit equipotent in vivo degranulation.

Authors:  Yevgeniy Yuzefpolskiy; Florian M Baumann; Vandana Kalia; Surojit Sarkar
Journal:  Cell Mol Immunol       Date:  2014-07-28       Impact factor: 11.530

10.  Senescence of activated stellate cells limits liver fibrosis.

Authors:  Valery Krizhanovsky; Monica Yon; Ross A Dickins; Stephen Hearn; Janelle Simon; Cornelius Miething; Herman Yee; Lars Zender; Scott W Lowe
Journal:  Cell       Date:  2008-08-22       Impact factor: 41.582

View more
  152 in total

1.  Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma.

Authors:  Zachary J Brown; Su Jong Yu; Bernd Heinrich; Chi Ma; Qiong Fu; Milan Sandhu; David Agdashian; Qianfei Zhang; Firouzeh Korangy; Tim F Greten
Journal:  Cancer Immunol Immunother       Date:  2018-06-29       Impact factor: 6.968

Review 2.  The potential of targeting Sin3B and its associated complexes for cancer therapy.

Authors:  David J Cantor; Gregory David
Journal:  Expert Opin Ther Targets       Date:  2017-10-09       Impact factor: 6.902

3.  T cells engineered to target senescence.

Authors:  Verena Wagner; Jesús Gil
Journal:  Nature       Date:  2020-07       Impact factor: 49.962

Review 4.  Liver macrophages in tissue homeostasis and disease.

Authors:  Oliver Krenkel; Frank Tacke
Journal:  Nat Rev Immunol       Date:  2017-03-20       Impact factor: 53.106

5.  Complement C1q mediates the expansion of periportal hepatic progenitor cells in senescence-associated inflammatory liver.

Authors:  Tung-Ching Ho; Er-Yea Wang; Kun-Huei Yeh; Yung-Ming Jeng; Jau-Hau Horng; Li-Ling Wu; Yi-Tzu Chen; Hsuan-Cheng Huang; Chia-Lang Hsu; Pei-Jer Chen; Shiou-Hwei Yeh; Ding-Shinn Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-05       Impact factor: 11.205

6.  Epstein-Barr virus miR-BART3-3p promotes tumorigenesis by regulating the senescence pathway in gastric cancer.

Authors:  Jia Wang; Xiang Zheng; Zailong Qin; Lingyu Wei; Yuanjun Lu; Qiu Peng; Yingxue Gao; Xuemei Zhang; Xiaoyue Zhang; Zhengshuo Li; Yuxin Fu; Peishan Liu; Can Liu; Qun Yan; Wei Xiong; Guiyuan Li; Jianhong Lu; Jian Ma
Journal:  J Biol Chem       Date:  2019-01-23       Impact factor: 5.157

7.  Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging.

Authors:  Denise P Muñoz; Steven M Yannone; Anneleen Daemen; Yu Sun; Funda Vakar-Lopez; Misako Kawahara; Adam M Freund; Francis Rodier; Jennifer D Wu; Pierre-Yves Desprez; David H Raulet; Peter S Nelson; Laura J van 't Veer; Judith Campisi; Jean-Philippe Coppé
Journal:  JCI Insight       Date:  2019-06-11

Review 8.  Oncogene-induced senescence: a double edged sword in cancer.

Authors:  Xue-Ling Liu; Jian Ding; Ling-Hua Meng
Journal:  Acta Pharmacol Sin       Date:  2018-04-05       Impact factor: 6.150

Review 9.  Strategies targeting cellular senescence.

Authors:  Yossi Ovadya; Valery Krizhanovsky
Journal:  J Clin Invest       Date:  2018-04-02       Impact factor: 14.808

Review 10.  Senescent cells: an emerging target for diseases of ageing.

Authors:  Bennett G Childs; Martina Gluscevic; Darren J Baker; Remi-Martin Laberge; Dan Marquess; Jamie Dananberg; Jan M van Deursen
Journal:  Nat Rev Drug Discov       Date:  2017-07-21       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.